Routine use of aspirin for primary prevention of cardiovascular disease is not warranted according to a new meta-analysis of randomised trials, which found that aspirin prophylaxis did not reduce cardiovascular death or cancer mortality in people without prior cardiac disease.
Archives of Internal Medicine
This site is intended for Registered Medical Practitioners.
To make the most of Endocrinology Update, you need to be logged in.